Nanobiosym

From Wikispooks
Revision as of 17:23, 23 May 2024 by Liaton9000 (talk | contribs) (→‎People: Added advisors.)
Jump to navigation Jump to search

Group.png Nanobiosym
(Big pharmaCrunchbase LinkedIn Twitter WebsiteRdf-entity.pngRdf-icon.png
Nanobiosym (logo).png
Formation2002
Founder Anita Goel
HeadquartersMassachusetts, USA
Type•  Genetics
•  nanotechnology
SloganWhere little things make a big difference
Membership•  Alfred Ford
•  Robert Langer
• David Lopez.jpeg David Lopez
•  John Palmer
•  Paul Maritz
•  Ratan Tata
•  John Abele
•  Tenley Albright
•  Tarun Khama
•  Homi Mullan
American nanotechnology company

Nanobiosym, formerly called Nanotune, is an American nanotechnology company based in Cambridge, Massachusetts.

History

Nanotune, Inc. was incorporated in Delaware on January 10, 2002.[1] The company received $448,844 in funding in 2004 from the Air Force Office of Scientific Research for research on "biomolecular motors (biomotors)".[2] On November 4, 2004, Nanotune changed its name to Nanobiosym.[3]

Nanobiosym Diagnostics was incorporated in Delaware on February 27, 2006.[4] On September 26, 2007, Nanobiosym announced that it and Nanobiosym Diagnostics had received a $2 million contract from the Defense Threat Reduction Agency (DTRA) to support the development of its Gene-RADAR genetic test, "a portable nanotechnology-enabled platform, that can rapidly and accurately detect genetic fingerprints from any biological organism." The funding was described by Nanobiosym founder Anita Goel as "our first defense contract" and "a major step towards establishing the US government as one of our long-term customers."[5]

A branch of Nanobiosym Diagnostics was incorporated in Massachusetts on December 19, 2008.[6]

Nanobiosym Advisory Services LLC was incorporated on July 20, 2012.[7]

At the annual meeting of the Clinton Global Initiative on September 30, 2015, Nanobiosym chairman Anita Goel announced the company's intention to deploy its Gene-RADAR genetic test "in Africa to stop Ebola and other infectious outbreaks."[8]

COVID-19

Nanobiosym paid $90,000 in 2020 to Ballard Partners' Brian Ballard and Dan Mcfaul to lobby the White House, the United States Department of Health and Human Services and the Overseas Private Investment Corporation on issues related to health and pharmaceuticals.[9]

On November 8, 2022, Nanobiosym received an Emergency Use Authorization (EUA) for a SARS-CoV-2 polymerase chain reaction (PCR) test called "The Nano Test for COVID-19".[10]

Organization

Nanobiosym's subsidiaries include Nanobiosym Diagnostics, Nanobiosym Education and Research Institute (NERI), Nanobiosym Global Initiative, and Nanobiosym Precision Testing Services.

People

Nanobiosym was founded by Anita Goel, who serves as Chairman and CEO. Goel is an advisor to the Taksha Institute, Lockheed Martin and the President's Council of Advisors on Science and Technology (PCAST), and served on the National Academy of Engineering's Committee on Manufacturing, Design, and Innovation. She also serves on the Canadian Institute for Advanced Research (CIFAR) research council, is a fellow of the World Technology Network, a fellow-at-large of the Santa Fe Institute, an Adjunct Professor at the Beyond Center for Fundamental Concepts in Physics, and an associate of the Harvard Department of Physics.[11]

Nanobiosym's board of advisors includes numerous influential individuals.[12] This includes Robert Langer, professor at the Massachusetts Institute of Technology (MIT) and co-founder of Moderna, and Ratan Tata, chairman of Tata Sons and advisor to JPMorgan Chase, the Bill & Melinda Gates Foundation's India AIDS Initiative and the Government of India.

Investors

Investors in Nanobiosym include:[13]

Nanobiosym has also received funding through grants and government contracts from:

Lobbying

Lobbying firms hired by Nanobiosym include:

References

  1. Delaware Department of State, Division of Corporations. (2019, August 31). Nanobiosym, Inc. OpenCorporates. https://opencorporates.com/companies/us_de/3477641
  2. 2004 DARPA Funding List. Executive Services Directorate. Retrieved February 13, 2024, from https://web.archive.org/web/20240213030308/https://www.esd.whs.mil/Portals/54/Documents/FOID/Reading%20Room/Science_and_Technology/12-F-1039_2004-DARPA-Funding-List.pdf
  3. Business Entity Summary - NANOBIOSYM, INC. Secretary of the Commonwealth of Massachusetts, Corporations Division. Retrieved February 13, 2024, from http://archive.today/2024.02.13-030048/https://corp.sec.state.ma.us/CorpWeb/CorpSearch/CorpSummary.aspx?sysvalue=tdckOJujVyIWJkN0yNBHllZ5GyHXxEQt6Kyz0tqy2uk-
  4. Delaware Department of State: Division of Corporations. (2019, August 31). Nanobiosym Diagnostics, Inc. OpenCorporates. https://opencorporates.com/companies/us_de/4116076
  5. Bagwadia, Z. (2007, September 26). Press Release: Nanobiosym Awarded $2M Contract From U.S. Defense Threat Reduction Agency (DTRA). Nanotechnology Now. http://archive.today/2024.05.07-205708/https://www.nanotech-now.com/news.cgi?story_id=25215
  6. Massachusetts Secretary of the Commonwealth, Corporations Division. (2024, February 5). Nanobiosym Diagnostics, Inc. OpenCorporates. https://opencorporates.com/companies/us_ma/000992043
  7. Massachusetts Secretary of the Commonwealth, Corporations Division. (2024, February 5). Nanobiosym Advisory Services LLC. OpenCorporates. https://opencorporates.com/companies/us_ma/462735849
  8. Webb, J. (2015, September 30). Nanobiosym’s Gene-RADAR® Unveiled as the “Next Frontier” in Healthcare Technology at the Clinton Global Initiative Annual Meeting. Business Wire. http://archive.today/2024.01.03-201152/https://www.businesswire.com/news/home/20150928006575/en/Nanobiosyms-Gene-RADAR®-Unveiled-as-the-‘Next-Frontier’-in-Healthcare-Technology-at-the-Clinton-Global-Initiative-Annual-Meeting
  9. Nanobiosym Diagnostics Lobbying Profile. (2023, July 24). OpenSecrets. https://www.opensecrets.org/federal-lobbying/clients/summary?cycle=2020&id=F307211
  10. The Nano Test for COVID-19 EUA Summary. (2022, November 8). Food and Drug Administration. https://web.archive.org/web/20230511163446/https://www.fda.gov/media/163098/download#:~:text=The%20Nano%20Test%20for%20COVID%2D19%20is%20a%20real%2Dtime,Nano%2DSaliva%20Collection%20Kit%2C%20when
  11. Anita Goel, MD, PhD. Taksha Institute. Retrieved November 27, 2023, from http://archive.today/2023.11.27-053732/https://www.taksha.org/advisors/goel/
  12. Team. Nanobiosym. Retrieved November 27, 2023, from http://archive.today/2023.11.27-044333/https://nanobiosym.com/our-team/
  13. Nanobiosym Company Profile: Valuation & Investors. PitchBook. Retrieved August 26, 2023, from http://archive.today/2023.08.27-062516/https://pitchbook.com/profiles/company/109455-31%23comparisons
  14. Experience | Dave Lopez. LinkedIn. Retrieved July 19, 2023, from http://archive.today/2023.07.19-225940/https://www.linkedin.com/in/dave-lopez-7b2306193/details/experience/
  15. Nanobiosym. Tracxn. Retrieved August 27, 2023, from https://web.archive.org/web/20230827063851/https://tracxn.com/d/companies/nanobiosym/__M-7FbYsfk7_1TLvf4Lcn_XBP301Qg_AGvsX32hsouXY
  16. Nanobiosym – an Unreasonable company. Unreasonable Group. Retrieved August 27, 2023, from https://web.archive.org/web/20230827061727/https://unreasonablegroup.com/ventures/nanobiosym
  17. Senate Office of Public Records. Nanobiosym Inc Hired Firms. OpenSecrets. Retrieved August 29, 2023, from https://www.opensecrets.org/federal-lobbying/clients/hired-firms?cycle=2021&id=D000054092
  18. Senate Office of Public Records. Nanobiosym Inc Hired Firms. OpenSecrets. Retrieved August 30, 2023, from https://web.archive.org/web/20230830021621/https://www.opensecrets.org/federal-lobbying/clients/hired-firms?cycle=2015&id=D000054092
  19. Senate Office of Public Records. Nanobiosym Inc Hired Firms. OpenSecrets. Retrieved August 30, 2023, from https://web.archive.org/web/20230830021815/https://www.opensecrets.org/federal-lobbying/clients/hired-firms?cycle=2009&id=D000054092
  20. Senate Office of Public Records. Nanobiosym Inc Hired Firms. OpenSecrets. Retrieved August 30, 2023, from http://archive.today/2023.08.30-021138/https://www.opensecrets.org/federal-lobbying/clients/hired-firms?cycle=2016&id=D000054092